Planning Helps Researchers Manage Information Overload

When Linus Pauling first began investigating vitamin C in the 1960s, it wasn't difficult for him to stay current with the latest findings--because he was the one doing most of the discovering. Now, he says, there are "probably 3,000 papers a year" that involve vitamin C. If anyone has the stamina to read them all, it would be Pauling, now 90. He is an avid reader, logging a minimum of five hours a day. Of course, Pauling's work goes way beyond the vitamin he claimed could cure the common cold

Written byA. J. S. Rayl
| 12 min read

Register for free to listen to this article
Listen with Speechify
0:00
12:00
Share

If anyone has the stamina to read them all, it would be Pauling, now 90. He is an avid reader, logging a minimum of five hours a day. Of course, Pauling's work goes way beyond the vitamin he claimed could cure the common cold and serve as a treatment for cancer. The two-time Nobel Prize winner's interests cover the whole spectrum of science, which means he is faced with absorbing an overwhelming amount of information. Despite his penchant for reading, Pauling says, "It's impossible to keep up with discoveries in science, even in a limited field such as vitamin C."

Scientists everywhere confront the dilemma of information overload. With the explosion of new findings in science in the last decade, publication has accelerated and the number of journals and science-oriented publications has increased. Keeping up with even a highly specialized field has become akin to running the Boston marathon.

A ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies